etravirine has been researched along with mebendazole in 2 studies
| Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (mebendazole) | Trials (mebendazole) | Recent Studies (post-2010) (mebendazole) |
|---|---|---|---|---|---|
| 572 | 90 | 321 | 2,089 | 184 | 438 |
| Protein | Taxonomy | etravirine (IC50) | mebendazole (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 5 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 5.5667 | |
| Calmodulin-domain protein kinase 1 | Toxoplasma gondii | 0.67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baidya, ATK; Das, B; Kumar, R; Mathew, AT; Yadav, AK | 1 |
2 review(s) available for etravirine and mebendazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Topics: Drug Discovery; Hydrogen Bonding; Molecular Structure; Prodrugs; Solubility | 2022 |